Literature DB >> 9875085

Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

J Kazmierczak1, Z Kornacewicz-Jach, M Kisly, R Gil, A Wojtarowicz.   

Abstract

OBJECTIVE: To report acute and mid-term electrocardiographic changes in patients with hypertrophic obstructive cardiomyopathy (HOCM) after alcohol ablation of the first large septal branch of the left anterior descending coronary artery; and to relate electrocardiographic data with the left ventricular outflow tract pressure gradients. PATIENTS: Nine consecutive symptomatic patients with HOCM (mean (SD) age 45 (12) years).
METHODS: Analysis of baseline and post-procedure ECGs and 24 hour ambulatory monitoring (up to six months). ECG data were related to left ventricular outflow tract pressure gradients.
RESULTS: One patient developed complete atrioventricular block requiring permanent pacing. The PR interval was significantly prolonged up to third month after ablation. Immediately after the procedure all patients developed right bundle branch block. At the sixth month of follow up, right bundle branch block was present in four patients. New anterior ST elevation developed immediately after ablation in five of the nine patients, and new Q waves in four. The QRS duration was significantly prolonged immediately after ablation and during follow up. There was significant but transient prolongation of QT-mean and QTc-mean intervals. QT dispersion, QTc dispersion, and JTc-mean interval were not affected. JT and JTc dispersions were transiently prolonged. No serious ventricular arrhythmias were recorded during Holter monitoring, either before or after the procedure. There were no significant correlations between the left ventricular outflow tract pressure gradient and QTc, QT-d, QTc-d, JTc, JT-d, JTc-d, or QRS duration before and after ablation.
CONCLUSIONS: Alcohol septal ablation for HOCM induces significant changes in the resting ECG in most patients, despite the occlusion of a relatively small artery. The changes include new Q waves, new bundle branch block, transient anterior ST segment elevation, atrioventricular block, and transient prolongation of QT interval.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875085      PMCID: PMC1761105          DOI: 10.1136/hrt.80.3.257

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  11 in total

1.  Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.

Authors:  C Knight; A S Kurbaan; H Seggewiss; M Henein; M Gunning; D Harrington; D Fassbender; U Gleichmann; U Sigwart
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

2.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Authors:  H Seggewiss; U Gleichmann; L Faber; D Fassbender; H K Schmidt; S Strick
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

3.  Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years.

Authors:  H D Schulte; W H Bircks; B Loesse; E A Godehardt; B Schwartzkopff
Journal:  J Thorac Cardiovasc Surg       Date:  1993-10       Impact factor: 5.209

4.  Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.

Authors:  G Buja; M Miorelli; P Turrini; P Melacini; A Nava
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

5.  Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group.

Authors:  L Kappenberger; C Linde; C Daubert; W McKenna; E Meisel; N Sadoul; L Chojnowska; L Guize; D Gras; X Jeanrenaud; L Rydén
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

6.  QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest.

Authors:  M Miorelli; G Buja; P Melacini; G Fasoli; A Nava
Journal:  Int J Cardiol       Date:  1994-06-15       Impact factor: 4.164

7.  Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Authors:  U Sigwart
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

8.  QT-interval abnormalities in hypertrophic cardiomyopathy.

Authors:  A Dritsas; E Sbarouni; D Gilligan; P Nihoyannopoulos; C M Oakley
Journal:  Clin Cardiol       Date:  1992-10       Impact factor: 2.882

9.  Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping.

Authors:  S A Rebergen; J Ottenkamp; J Doornbos; E E van der Wall; J G Chin; A de Roos
Journal:  J Am Coll Cardiol       Date:  1993-01       Impact factor: 24.094

10.  Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone.

Authors:  L Fei; A K Slade; A A Grace; M Malik; A J Camm; W J McKenna
Journal:  Pacing Clin Electrophysiol       Date:  1994-11       Impact factor: 1.976

View more
  5 in total

1.  Cardiac MRI detected septal and lateral myocardial infarction by alcohol septal ablation through the intermediate artery.

Authors:  Mike Saji; Itaru Takamisawa; Nobuo Iguchi; Morimasa Takayama
Journal:  Heart Vessels       Date:  2013-01-11       Impact factor: 2.037

2.  Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.

Authors:  Travis J Moss; Matthew M Zipse; Mori J Krantz; William H Sauer; Ernesto E Salcedo; Joseph L Schuller
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-11       Impact factor: 1.468

Review 3.  Value of electro-vectorcardiogram in hypertrophic cardiomyopathy.

Authors:  Andrés Ricardo Pérez-Riera; Augusto Armando de Lucca; Raimundo Barbosa-Barros; Frank G Yanowitz; Silvia Fortunato de Cano; Manuel Nicolás Cano; Antônio Carlos Palandri-Chagas
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-07       Impact factor: 1.468

Review 4.  Percutaneous transluminal septal myocardial ablation.

Authors:  D N Rubin; E M Tuzcu; H M Lever
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

5.  Percutaneous transluminal radiofrequency closure of the coronary artery in animal studies.

Authors:  Chenyun Zhang; Wei Yi; Yunchang Cai; Shounian Fang; Xinan Jiang; Anzhi Wen; Qiang Wu
Journal:  Exp Ther Med       Date:  2013-08-16       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.